Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Aris Liakos"'
Autor:
Theodoros MICHAILIDIS, Aris LIAKOS, Nikolaos KAKALETSIS, Ioannis AVGERINOS, Stylianos MAMALIS, Sophia ASPRAGATHOU
Publikováno v:
Archives of the Balkan Medical Union, Vol 57, Iss 3, Pp 301-306 (2022)
Introduction. Multisystem inflammatory syndrome in adults (MIS-A) is a rare but potentially life-threatening sequel of SARS-CoV-2 infection, requiring early recognition and treatment. Nevertheless, it is often hard to distinguish MIS-A from other
Externí odkaz:
https://doaj.org/article/6738162ede4c4b36840c7cab26933128
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 6 (2015)
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel class of antihyperglycaemic agents with an insulin-independent mode of action. Dapagliflozin is a member of the SGLT2 inhibitors class that has received marketing authorization in Europe a
Externí odkaz:
https://doaj.org/article/edf49e626c334d7886c4a3aad9c17624
Autor:
Thomas Karagiannis, Ioannis Avgerinos, Aris Liakos, Stefano Del Prato, David R. Matthews, Apostolos Tsapas, Eleni Bekiari
Publikováno v:
Diabetologia. 65:1251-1261
Aims/hypothesis Tirzepatide is a novel dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA) currently under review for marketing approval. Individual trials have assessed the clinical profile of
Publikováno v:
Oxford Medical Case Reports. 2022
Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes (POEMS) is a rare paraneoplastic syndrome, and its diagnosis is based on a series of clinical and laboratory findings. We present the case of a 46-year-old woman who was p
Autor:
David R. Matthews, Panagiota Kakotrichi, Thomas Karagiannis, Eleni Bekiari, Aris Liakos, Ioannis Avgerinos, Theodoros Michailidis, Apostolos Tsapas
Publikováno v:
Diabetes, Obesity and Metabolism. 24:106-114
Aim To assess the efficacy and safety of sotagliflozin in patients with type 2 diabetes mellitus. Methods We searched Medline, Embase, the Cochrane Library, and grey literature sources up to August 2021 for randomized controlled trials (RCTs) that co
Publikováno v:
Diabetes, obesitymetabolismREFERENCES.
Autor:
Maria Mainou, Thomas Karagiannis, Theodoros Michailidis, David R. Matthews, Aris Liakos, Eleni Bekiari, Apostolos Tsapas, Georgia Papanastasiou, Ioannis Avgerinos
Publikováno v:
Diabetes, Obesity and Metabolism. 23:2395-2401
We performed a systematic review and meta-analysis of randomized controlled trials to assess the efficacy and safety of the novel, ultra-rapid acting insulins aspart and lispro in adults with type 1 or type 2 diabetes. Our primary outcome was change
Autor:
Apostolos Tsapas, Panagiota Kakotrichi, Thomas Karagiannis, Apostolos Manolopoulos, Konstantinos Malandris, Aris Liakos, Ioannis Avgerinos, Georgios Tousinas, Eleni Bekiari, David R. Matthews, Chrysanthi Mantsiou
Publikováno v:
Diabetes, Obesity and Metabolism. 23:2116-2124
Aim To compare the effects of glucose-lowering drugs on body weight and blood pressure in adults with type 2 diabetes. Methods We searched Medline, Embase, the Cochrane Library, and grey literature sources until 29 September 2020 for randomized contr
Autor:
Chrysanthi Mantsiou, Aris Liakos, Maria Mainou, Nikolaos Papanas, Apostolos Tsapas, Eleni Bekiari
Publikováno v:
The International Journal of Lower Extremity Wounds. :153473462311698
Systematic reviews and meta-analyses lie on the top of the evidence hierarchy because they utilize explicit methods for literature search and retrieval of studies relevant to the review question as well as robust methodology for quality assessment of